CANADA, May 19, 2020 (GREENMARKETREPORT) Zenabis Global Inc. (OTC:ZBISF) reported rising revenue in Canadian dollars for the first quarter ending March 31, 2020. Zenabis‘s revenue rose 18% sequentially to $12.6 million and easily surpassing last year’s $4.1 million for the same time period. The net losses dropped dramatically to $1.5 million from...
U.S, March 6, 2020 (MERRYJANE) Researchers found that medical cannabis helps alleviate anxiety, depression, and sleep disturbances among patients suffering from fibromyalgia.
A new research study found that medical cannabis can improve the efficacy of standard analgesic treatments for fibromyalgia.
Fibromyalgia (FM)...
TORONTO, October 11, 2019 – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”) today announced the appointment of former U.S. congressman Stephen Buyer to the Company’s Board of Directors. The Company also announced that it will complete a consolidation of its class A multiple...
U.S, March 23, 2020 (CANNABISBUSINESSTIMES) The DEA issued a notice of proposed rulemaking to amend its regulations to comply with the requirements of the Controlled Substances Act in an effort to move forward with cannabis cultivation for research purposes.
The Drug Enforcement...
U.S, March 30, 2020 (MERRYJANE) At least one doctor in the Great White North wants to see if weed’s anti-inflammatory and immune-boosting properties can help COVID-19 patients recover from the deadly virus.
As the coronavirus pandemic continues to spread around the world, scientists...
U.S May 26, 2020 (CANNABISBUSINESSTIMES) From equipment selection to best practices and safety considerations, here is what to consider when processing cannabis and hemp.
While THC and CBD come from the same plant, processing cannabis and processing hemp are two unique...
UNITED STATES, September 25, 2019 (PROACTIVE INVESTORS) - The five-year deal will see the companies extract CBD and other elements at FSD's facility using World-Class' machinery.
FSD Pharma Inc (CSE:HUGE) (OTC:FSDDF) has signed a letter of intent to create a joint venture between its subsidiary FV Pharma Inc and World-Class Extractions...
U.S, February 27, 2020 (ANALYTICALCANNABIS) More older adults than ever before are using cannabis, but their healthcare providers are still too hesitant to talk about it, say researchers.
After analyzing a new wave of data from the National Survey on Drug Use and...
U.S, April 21, 2020 (ANALYTICALCANNABIS) Insomnia is one of the most common sleep disorders in the world. Its prevalence sits between 10-to-30 percent in the general population and climbs as high as 50-to-60 percent for older adults and people with medical or mental ill health.
U.S, February 21, 2020 (HEMPGAZETTE) It’s looking like Thunderbirds are go for a medical cannabis insomnia product developed by Zelira Therapeutics (ASX:ZLD).
In case you’re wondering who Zelira is, you might recognise it by its previous name – Zelda Therapeutics. The name change came...